Practical usage of ciclosporin 0.09% for moderate-severe dry eye disease (Perth)
Date: 3/09/2024 (AWST)
Venue: QT Perth, 133 Murray Street, Perth, WA, 6000
Provider: Sun Pharma ANZ
Contact: Sarah Kim, [E] sarah.kim@sunpharma.com, [P] 0426788600
Activity Outline
Join our interactive CPD educational dinner event at QT Perth where Leigh Plowman (founder of Dry Eye Directory) will explore the role of Cequa (ciclosporin 0.09%) in the management of moderate to severe dry eye disease and discuss the practical considerations with its usage, including prescribing, patient selection and patient education. Real-life clinical application to achieve best patient outcomes using Cequa will be examined through case studies and interactive discussions.
For further details and to register your space for the event, please click the link:
https://www.eventbrite.com.au/e/practical-usage-of-ciclosporin-009-for-moderate-severe-dry-eye-disease-wa-tickets-953013758807
Learning Objectives
- Understand why treating underlying inflammation is important in moderate-severe dry eye disease for long term disease management
- Understand the role of ciclosporin 0.09% in the management of moderate-severe dry eye disease
- Develop a deeper understanding of the practical considerations in ciclosporin 0.09% management therapy including patient education, prescribing and expectations
- Understand how to utilise ciclosporin 0.09% for moderate-severe dry eye disease in clinical practice for best patient outcomes
Max CPD hours awarded: 2.5
Session Information
| Name |
|---|
| Practical use of ciclosporin 0.09% in moderate-severe dry eye disease |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 2.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 2.5 |